Ultrasound Guided Trigeminal Nerve Block in Maxillofacial Surgeries
Evaluating the Perioperative Analgesic Effect of Ultrasound-guided Trigeminal Nerve Block in Adult Patients Undergoing Maxillo-facial Surgery Under General Anesthesia: A Randomized Controlled Study
1 other identifier
interventional
25
1 country
1
Brief Summary
This study aims to evaluate the perioperative analgesic effect of USG Trigeminal Nerve Block in adult patients undergoing maxillofacial surgery. We hypothesized that giving USG-guided TNB in patients undergoing maxilla-facial surgery could reduce the requirements of opioids perioperatively and avoid the side effects of opioids used. The aim of this double-blind study is to evaluate the effect of USG-guided TNB intra- and post-operatively in terms of pain relief, opioid consumption and adverse effects in patients undergoing such elective surgeries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 25, 2022
CompletedFirst Posted
Study publicly available on registry
October 5, 2022
CompletedStudy Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2023
CompletedApril 30, 2025
December 1, 2022
4 months
September 25, 2022
April 26, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
total fentanyl consumption during the intraoperative period.
the amount of the fentanyl that will be used intraoperatively as analgesia
immediately at the end of the surgery
Study Arms (2)
Trigeminal Nerve Block (TNB)
ACTIVE COMPARATORpatients will receive general anesthesia followed 5 ml of 0.25% Bupivacaine for TGB under USG after induction of anesthesia (Block Group).
control
NO INTERVENTIONpatients will receive general anesthesia only (Control Group).
Interventions
Eligibility Criteria
You may qualify if:
- American society of anesthesia (ASA) criteria I/II
- Scheduled for elective unilateral maxillo-facial surgery
You may not qualify if:
- Patients with polytrauma and fracture base of skull.
- Patients with known allergy to the study drugs.
- Patients with coagulopathy.
- Patients with infection at puncture site.
- Patients necessitating postoperative ventilation from the start, since it will be difficult to assess respiratory depression and postoperative pain.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Suez Canal University
Ismailia, 2685, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Abdelrhman Alshawadfy, MD
Suez Canal University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of anesthesia and intensive care
Study Record Dates
First Submitted
September 25, 2022
First Posted
October 5, 2022
Study Start
November 1, 2022
Primary Completion
February 28, 2023
Study Completion
March 30, 2023
Last Updated
April 30, 2025
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share